Drug Profile
Nicotine abuse vaccine TA-NIC
Alternative Names: TA-NICLatest Information Update: 24 Aug 2011
Price :
$50
*
At a glance
- Originator ImmuLogic Pharmaceutical
- Developer Celtic Pharma
- Class Drug withdrawal therapies; Smoking cessation therapies; Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Smoking withdrawal
Most Recent Events
- 08 May 2006 Celtic Pharma has received approval to conduct a phase II trial for the treatment of smoking withdrawal in the UK
- 07 Mar 2005 Data from a media release have been added to the Drug Withdrawl therapeutic trials and immunogenicity sections
- 16 Jul 2004 Data from a media release have been added to the adverse events and Drug Withdrawal immunogenicity sections